Frontlight ResearchEarly access
Hypertrophic cardiomyopathy trials in France
4 of 8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 17 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Where
- Amiens, Haguenau, Lille, Montpellier, Poitiers, Saint-Herblain, Toulon
- Age
- 18 years and over
- People
- 1,700 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05489705 - No phaseNot yet taking people in FranceBiological Collection for the Purpose of Exploring Genetic and Clinical-biological Factors Associated With Variability in Response to Mavacamten in the Treatment of Obstructive Hypertrophic Cardiomyopathy
- Where
- Boulogne-Billancourt, Le Kremlin-Bicêtre, Paris
- Age
- 18 years and over
- People
- 300
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07439952 - No phaseTaking peopleOptimisation of Decision Making for Defibrillator Implantation in Hypertrophic Cardiomyopathy
- Where
- Boulogne-Billancourt
- Age
- 16 years and over
- People
- 2,000
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT03846297 - No phaseTaking peopleFrench Hypertrophic Cardiomyopathy Observatory
- Where
- Paris
- Age
- 15 years and over
- People
- 600
- Run by
- French Cardiology Society
See details and how to joinNCT01091480